BOB体育

Skip to main content
  • Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma (RADICAL)

    The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin鈥�

    Investigator
    William Slayton
    Ages
    3 Years - 39 Years
    Sexes
    All
  • PBTC-060

    Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells鈥�

    Investigators
    Elias Sayour, Jennifer F King
    Ages
    1 Year - 21 Years
    Sexes
    All